Abstract
Ataxia-telangiectasia (A-T) is an autosomal recessive neurological syndrome of considerable interest because homozygotes are highly predisposed to cancer. Vigorous casefinding in the United States in 1970-72 and 1980-84 identified 231 white, 29 black, and three Oriental A-T cases that provide information about the incidence and gene frequency of A-T. White patients identified in this study were born at the rate of 3.0 per million live births in the U.S. in the years 1965-69. The highest observed incidence was in the state of Michigan for 1965-69, where identified white A-T patients were born at the rate of 11.3 per million births. Based on the incidence data, the minimum frequency of a single hypothetical A-T gene in the U.S. white population was estimated to be .0017. Pedigree analysis, which estimates the gene frequency from the proportion of affected close blood relatives of homozygous probands, estimated the most likely gene frequency to be .007 on the assumption that A-T is a single homogeneous genetic syndrome, with 95% confidence limits of .0012-.02. Given that complementation analysis has demonstrated the genetic heterogeneity of A-T, the A-T heterozygote frequency will probably fall between 0.68% and 7.7%, with 2.8% being the most likely estimate.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Akande E. O., Bonnar J., Carr P. J., Corker C. S., Dutton A., MacKinnon P. C., Robinson D. Effect of synthetic gonadotrophin-releasing hormone in secondary amenorrhoea. Lancet. 1972 Jul 15;2(7768):112–116. doi: 10.1016/s0140-6736(72)91598-x. [DOI] [PubMed] [Google Scholar]
- Elston R. C., Stewart J. A general model for the genetic analysis of pedigree data. Hum Hered. 1971;21(6):523–542. doi: 10.1159/000152448. [DOI] [PubMed] [Google Scholar]
- Jaspers N. G., Painter R. B., Paterson M. C., Kidson C., Inoue T. Complementation analysis of ataxia-telangiectasia. Kroc Found Ser. 1985;19:147–162. [PubMed] [Google Scholar]
- McKusick V. A., Cross H. E. Ataxia-telangiectasia and Swiss-type agammaglobulinemia. Two genetic disorders of the immune mechanism in related Amish sibships. JAMA. 1966 Feb 28;195(9):739–745. doi: 10.1001/jama.195.9.739. [DOI] [PubMed] [Google Scholar]
- Morrell D., Cromartie E., Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J Natl Cancer Inst. 1986 Jul;77(1):89–92. [PubMed] [Google Scholar]
- Mudd S. H., Skovby F., Levy H. L., Pettigrew K. D., Wilcken B., Pyeritz R. E., Andria G., Boers G. H., Bromberg I. L., Cerone R. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985 Jan;37(1):1–31. [PMC free article] [PubMed] [Google Scholar]
- Swift M., Caldwell R. J., Chase C. Reassessment of cancer predisposition of Fanconi anemia heterozygotes. J Natl Cancer Inst. 1980 Nov;65(5):863–867. [PubMed] [Google Scholar]
- Swift M., Chase C. Cancer in families with xeroderma pigmentosum. J Natl Cancer Inst. 1979 Jun;62(6):1415–1421. [PubMed] [Google Scholar]
- Swift M., Sholman L., Perry M., Chase C. Malignant neoplasms in the families of patients with ataxia-telangiectasia. Cancer Res. 1976 Jan;36(1):209–215. [PubMed] [Google Scholar]